Exenatide inhibits NF-κB and attenuates ER stress in diabetic cardiomyocyte models
Figure 5.Re-activation of NF-κB induces cardiomyocyte death and inflammation. (A) CCK8 assay for cell viability. (B) ELISA assay for caspase-3 activity. (C, D) qPCR assay for MCP1 and TNFα transcription. *P<0.05.